News

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

Roche Puts Hold on Tamiflu in United States

Roche Puts Hold on Tamiflu in US

Roche (Basel, Switzerland, www.roche.com) has put a temporary halt on distribution of the influenza vaccine "Tamiflu" to the United Sates in an effort to deter companies from stockpiling the vaccine for employee use, according to an article in the Oct. 27 edition of The New York Times.

According to the report, the hoarding is a reaction to the recent avian flu pandemic, which has killed more than 60 people in Asia, but has not threatened the United States. Roche representatives stated that there are currently sufficient allotments of the vaccine in the United States and additional quantities will be released as the need arises. However, wholesalers were advised to limit the amount of drug distributed to pharmacies to “preserve their inventory until the beginning of flu season.”

Roche has also suspended shipments to Canada and limited supplies to Germany and Switzerland, according to The Times.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content